1 Introduction The goal in growth-promoting therapy in children with growth disorders is to increase the child's growth rate and adult height while approaching a physiological pattern of growth hormone (GH) secretion
Each component targets tissue repair through a different mechanism, creating a multi-pathway approach to regeneration research
doi:10.5935/1518-0557.20190033 Pooyandjoo M, Nouhi M, Shab-Bidar S, Djafarian K, Olyaeemanesh A
outlined several systemic advantages of GLP-1 RAs, including weight loss, glycemic control, cardiovascular protection (e.g., reduced incidence of myocardial infarction and stroke), and their role as a non-surgical alternative to bariatric procedures
Typically, people qualify for this treatment if they have a body mass index (BMI) of 27 or higher along with weight-related health issues, or a BMI of 30 or more
Good communication between doctors and patients is critical